Revascularization Device News Today

Founded in 2004, Penumbra has grown into a global healthcare company specializing in innovative therapies. With over 4000 employees, the company offers products in more than 100 markets worldwide....

Piper Sandler reissued their overweight rating on shares of Penumbra (NYSE:PEN – Free Report) in a report published on Friday, Benzinga reports. Piper Sandler currently has a $290.00 price target on the stock, down from their prior price target of $310.00. A number of other brokerages also recently weighed in on PEN. Morgan Stanley decreased […]

JPMorgan Chase & Co. cut shares of Penumbra (NYSE:PEN – Free Report) from an overweight rating to a neutral rating in a research report released on Friday morning, Marketbeat Ratings reports. The brokerage currently has $250.00 price objective on the stock, down from their previous price objective of $284.00. Several other brokerages have also recently […]

Penumbra (NYSE:PEN – Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.05, Briefing.com reports. The firm had revenue of $284.68 million for the quarter, compared to the consensus estimate of $286.62 million. Penumbra had a […]

Fmr LLC lessened its holdings in shares of Penumbra, Inc. (NYSE:PEN – Free Report) by 0.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,016,984 shares of the company’s stock after selling 32,197 shares during the quarter. Fmr LLC […]

Shares of Penumbra, Inc. (NYSE:PEN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten analysts that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1 […]

Artisan Partners Limited Partnership increased its stake in shares of Penumbra, Inc. (NYSE:PEN – Free Report) by 24.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 100,235 shares of the company’s stock after purchasing an additional 19,819 shares during the period. […]

Shares of Penumbra, Inc. (NYSE:PEN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 1-year price […]

Jump Financial LLC increased its position in Penumbra, Inc. (NYSE:PEN – Free Report) by 212.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,694 shares of the company’s stock after purchasing an additional 6,594 shares during the quarter. Jump Financial LLC’s holdings in Penumbra […]

Securian Asset Management Inc. trimmed its stake in shares of Penumbra, Inc. (NYSE:PEN – Free Report) by 5.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,255 shares of the company’s stock after selling 204 shares during the quarter. Securian Asset […]